NCT00387049
- Conditions
- Behavior, Health Behavior, Smoking Cessation
- Locations
-
- University of Vermont Burlington, Vermont, United States
Clinical trial condition
Smoking Cessation
Explore clinical trials studying Smoking Cessation. Study availability and eligibility vary by location and protocol.
901 public trials
83 recruiting studies
Smoking Cessation trial results
NCT00799279
- Conditions
- Behavior, Health Behavior, Smoking, +1 more
- Locations
-
Not specified
NCT00141167
- Conditions
- Behavior, Health Behavior, Smoking Cessation
- Locations
-
- Pfizer Investigational Site Anyang-si, Gyeonggi-do, South Korea
- Pfizer Investigational Site Daegu, South Korea
- Pfizer Investigational Site Seoul, South Korea
- Pfizer Investigational Site Seoul, South Korea
NCT00749944
- Conditions
- Behavior, Health Behavior, Smoking Cessation
- Locations
-
- Pfizer Investigational Site Austin, Texas, United States
- Pfizer Investigational Site San Antonio, Texas, United States
NCT00594204
- Conditions
- Behavior, Health Behavior, Smoking Cessation
- Locations
-
- Pfizer Investigational Site Fortaleza, Ceará, Brazil
- Pfizer Investigational Site Porto Alegre, Centro, Brazil
- Pfizer Investigational Site Juiz de Fora, Minas Gerais, Brazil
- Pfizer Investigational Site Botucatu, São Paulo, Brazil
NCT00135265
- Conditions
- Behavior, Health Behavior, Health Care Quality, Access, and Evaluation, +1 more
- Locations
-
- University of Rochester Rochester, New York, United States
Completed
Waterpipe Cessation Intervention Study
NCT01135173
- Conditions
- Behavior, Health Behavior, Pipe Smoking, +3 more
- Locations
-
- Syrian Center for Tobacco Studies Aleppo, Syria
NCT01121887
- Conditions
- Behavior, Health Behavior, Smoking, +3 more
- Locations
-
- Asgeir R. Helgason Stockholm, Sweden
Completed
Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD).
NCT00285012
- Conditions
- Behavior, Health Behavior, Smoking Cessation
- Locations
-
- Pfizer Investigational Site Birmingham, Alabama, United States
- Pfizer Investigational Site Los Angeles, California, United States
- Pfizer Investigational Site Los Angeles, California, United States
- Pfizer Investigational Site Denver, Colorado, United States
NCT01085032
- Conditions
- Behavior, Behavioral Symptoms, Chemically-Induced Disorders, +6 more
- Locations
-
- Four privately- or NGO-sponsored adult primary care clinics Aleppo, Syria